Works matching IS 2076393X AND DT 2023 AND VI 11 AND IP 9
Results: 117
Streptococcus pyogenes : Pathogenesis and the Current Status of Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1510, doi. 10.3390/vaccines11091510
- By:
- Publication type:
- Article
Exploring the Effects of Vitamin D and Vitamin A Levels on the Response to COVID-19 Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1509, doi. 10.3390/vaccines11091509
- By:
- Publication type:
- Article
Intention, Motivation, and Empowerment: Factors Associated with Seasonal Influenza Vaccination among Healthcare Workers (HCWs).
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1508, doi. 10.3390/vaccines11091508
- By:
- Publication type:
- Article
Systematic Mapping of Research on Vaccine-Preventable Diseases in Children in Sub-Saharan Africa: A Decennial Scientometric Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1507, doi. 10.3390/vaccines11091507
- By:
- Publication type:
- Article
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1506, doi. 10.3390/vaccines11091506
- By:
- Publication type:
- Article
A Lesson from a Measles Outbreak among Healthcare Workers in a Single Hospital in South Korea: The Importance of Knowing the Prevalence of Susceptibility.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1505, doi. 10.3390/vaccines11091505
- By:
- Publication type:
- Article
Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1504, doi. 10.3390/vaccines11091504
- By:
- Publication type:
- Article
ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1503, doi. 10.3390/vaccines11091503
- By:
- Publication type:
- Article
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1502, doi. 10.3390/vaccines11091502
- By:
- Publication type:
- Article
Vaccinating Welders against Pneumococcus: Evidence from a Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1495, doi. 10.3390/vaccines11091495
- By:
- Publication type:
- Article
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1494, doi. 10.3390/vaccines11091494
- By:
- Publication type:
- Article
The Effectiveness of Paracetamol to Reduce the Post-Vaccination SARS-CoV-2 Adverse Effects in an Italian Vaccination Center.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1493, doi. 10.3390/vaccines11091493
- By:
- Publication type:
- Article
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1501, doi. 10.3390/vaccines11091501
- By:
- Publication type:
- Article
A Field Efficacy Trial of Recombinant Porcine Circovirus Type 2d Vaccine in Three Herds.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1497, doi. 10.3390/vaccines11091497
- By:
- Publication type:
- Article
Strategies and Trends in COVID-19 Vaccination Delivery: What We Learn and What We May Use for the Future.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1496, doi. 10.3390/vaccines11091496
- By:
- Publication type:
- Article
Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1500, doi. 10.3390/vaccines11091500
- By:
- Publication type:
- Article
Development of a Novel Canine Parvovirus Vaccine Capable of Stimulating Protective Immunity in Four-Week-Old Puppies in the Face of High Levels of Maternal Antibodies.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1499, doi. 10.3390/vaccines11091499
- By:
- Publication type:
- Article
Efficiency of NHEJ-CRISPR/Cas9 and Cre-LoxP Engineered Recombinant Turkey Herpesvirus Expressing Pasteurella multocida OmpH Protein for Fowl Cholera Prevention in Ducks.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1498, doi. 10.3390/vaccines11091498
- By:
- Publication type:
- Article
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1492, doi. 10.3390/vaccines11091492
- By:
- Publication type:
- Article
The Social Ecological Model: A Framework for Understanding COVID-19 Vaccine Uptake among Healthcare Workers—A Scoping Review.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1491, doi. 10.3390/vaccines11091491
- By:
- Publication type:
- Article
HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1490, doi. 10.3390/vaccines11091490
- By:
- Publication type:
- Article
Hesitancy in COVID-19 Vaccine Uptake and Its Correlated Factors Using Multi-Theory Model among Adult Women: A Cross-Sectional Study in Three States of Somalia.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1489, doi. 10.3390/vaccines11091489
- By:
- Publication type:
- Article
Combinatorial Effects of miRNAs in HSV-2 Infection of Macrophages: An In Silico and In Vitro Integration Approach.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1488, doi. 10.3390/vaccines11091488
- By:
- Publication type:
- Article
Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1487, doi. 10.3390/vaccines11091487
- By:
- Publication type:
- Article
Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1486, doi. 10.3390/vaccines11091486
- By:
- Publication type:
- Article
CD4 + T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1485, doi. 10.3390/vaccines11091485
- By:
- Publication type:
- Article
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1484, doi. 10.3390/vaccines11091484
- By:
- Publication type:
- Article
Safety of the Administration of an Inactivated PCV2a/PCV2b/ Mycoplasma Hyopneumoniae Vaccine to Pregnant and Lactating Sows and Gilts.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1483, doi. 10.3390/vaccines11091483
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Infections in Polish Pediatric Patients from an Expert Perspective.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1482, doi. 10.3390/vaccines11091482
- By:
- Publication type:
- Article
Updated Considerations for the Immunopharmacological Aspects of the "Talented mRNA Vaccines".
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1481, doi. 10.3390/vaccines11091481
- By:
- Publication type:
- Article
Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1480, doi. 10.3390/vaccines11091480
- By:
- Publication type:
- Article
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1479, doi. 10.3390/vaccines11091479
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1478, doi. 10.3390/vaccines11091478
- By:
- Publication type:
- Article
Clinical and Molecular Epidemiology of Hemorrhagic Fever with Renal Syndrome Caused by Orthohantaviruses in Xiangyun County, Dali Prefecture, Yunnan Province, China.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1477, doi. 10.3390/vaccines11091477
- By:
- Publication type:
- Article
Analyzing the Costs and Benefits of Utilizing a Mixed-Strategy Approach in Infectious Disease Control under a Voluntary Vaccination Policy.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1476, doi. 10.3390/vaccines11091476
- By:
- Publication type:
- Article
Evaluation of the Immunological Efficacy of an LNP-mRNA Vaccine Prepared from Varicella Zoster Virus Glycoprotein gE with a Double-Mutated Carboxyl Terminus in Different Untranslated Regions in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1475, doi. 10.3390/vaccines11091475
- By:
- Publication type:
- Article
PD-L1 Is Involved in the Development of Non-Hodgkin's Lymphoma by Mediating Circulating Lymphocyte Apoptosis.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1474, doi. 10.3390/vaccines11091474
- By:
- Publication type:
- Article
Evaluation of Aluminium Hydroxide Nanoparticles as an Efficient Adjuvant to Potentiate the Immune Response against Clostridium botulinum Serotypes C and D Toxoid Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1473, doi. 10.3390/vaccines11091473
- By:
- Publication type:
- Article
The Key Site Variation and Immune Challenges in SARS-CoV-2 Evolution.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1472, doi. 10.3390/vaccines11091472
- By:
- Publication type:
- Article
Understanding COVID-19 Vaccine Acceptance among Latin American Health Workers: Implications for Designing Interventions.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1471, doi. 10.3390/vaccines11091471
- By:
- Publication type:
- Article
Recombinant Attenuated Edwardsiella piscicida Vaccine Displaying Regulated Lysis to Confer Biological Containment and Protect Catfish against Edwardsiellosis.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1470, doi. 10.3390/vaccines11091470
- By:
- Publication type:
- Article
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1469, doi. 10.3390/vaccines11091469
- By:
- Publication type:
- Article
Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1468, doi. 10.3390/vaccines11091468
- By:
- Publication type:
- Article
A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1467, doi. 10.3390/vaccines11091467
- By:
- Publication type:
- Article
Orogenital Human Papillomavirus Infection and Vaccines: A Survey of High- and Low-Risk Genotypes Not Included in Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1466, doi. 10.3390/vaccines11091466
- By:
- Publication type:
- Article
Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1465, doi. 10.3390/vaccines11091465
- By:
- Publication type:
- Article
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1464, doi. 10.3390/vaccines11091464
- By:
- Publication type:
- Article
Factors Affecting COVID-19 Vaccine Acceptance among Pregnant Women: A Cross Sectional Study from Abha City, Saudi Arabia.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1463, doi. 10.3390/vaccines11091463
- By:
- Publication type:
- Article
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1462, doi. 10.3390/vaccines11091462
- By:
- Publication type:
- Article
Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1461, doi. 10.3390/vaccines11091461
- By:
- Publication type:
- Article